LAZARD ASSET MANAGEMENT LLC - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 134 filers reported holding PDL BIOPHARMA INC in Q1 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
LAZARD ASSET MANAGEMENT LLC ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q4 2019$458,000
+3423.1%
141,208
+3392.7%
0.00%
Q1 2016$13,000
-99.3%
4,043
-98.6%
0.00%
-100.0%
Q1 2015$1,988,000
-13.2%
282,653
-4.8%
0.00%
-20.0%
Q4 2014$2,290,000
-14.1%
297,020
-16.8%
0.01%
-16.7%
Q3 2014$2,666,000
-9.9%
357,020
+16.8%
0.01%0.0%
Q2 2014$2,958,000
-3.6%
305,600
-17.3%
0.01%
-14.3%
Q1 2014$3,070,000
+282.8%
369,494
+288.6%
0.01%
+250.0%
Q4 2013$802,000
+101.5%
95,079
+90.2%
0.00%
+100.0%
Q3 2013$398,00050,0000.00%
Other shareholders
PDL BIOPHARMA INC shareholders Q1 2020
NameSharesValueWeighting ↓
Argent Trust Co 41,405$102,2700.01%
Diversified Trust Co 11,029$26,4690.00%
HANCOCK WHITNEY CORP 128,396$00.00%
RHUMBLINE ADVISERS 612$1,5110.00%
Ancora Advisors LLC 4,948$00.00%
Westside Investment Management, Inc. 500$00.00%
View complete list of PDL BIOPHARMA INC shareholders